We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Rivastigmine for Intensive Care Unit (ICU) Delirium

This study has been terminated.
(The study is prematurely terminated due to a safety issue)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00704301
First Posted: June 24, 2008
Last Update Posted: August 13, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
ZonMw: The Netherlands Organisation for Health Research and Development
Novartis
Hersenstichting
Information provided by:
UMC Utrecht
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2010
  Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):